SC
ZYME icon

SummitTX Capital’s Zymeworks ZYME Stock Holding History

SummitTX Capital’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.51M Sell
210,802
-110,625
-34% -$2.81M 0.14% 172
2026
Q1 		$8.05M Buy
321,427
+97,159
+43% +$2.3M 0.25% 94
2025
Q4 		$5.9M Buy
+224,268
New +$4.89M 0.18% 137

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

SummitTX Capital's ZYME Position: Q2 2026 in Review

SummitTX Capital reduced its Zymeworks (ZYME) stake by 34% in Q2 2026, selling an estimated $2.81M and leaving 210,802 shares worth $5.51M. The position accounts for 0.14% of the portfolio, ranked #172.

SummitTX Capital first reported a position in ZYME in Q4 2025 and has held it in 3 quarters since. The position peaked at $8.05M in Q1 2026. 203 funds tracked by Wall St. Rank hold ZYME as of Q2 2026.

  • SummitTX Capital held 210,802 shares of Zymeworks worth $5.51M as of Q2 2026.
  • SummitTX Capital sold 110,625 Zymeworks shares in Q2 2026, an estimated $2.81M.
  • Zymeworks made up 0.14% of SummitTX Capital's portfolio in Q2 2026, its #172 holding.
  • SummitTX Capital first reported a position in Zymeworks in Q4 2025 and has held it in 3 quarters since.
  • SummitTX Capital's Zymeworks position peaked at $8.05M in Q1 2026.
  • 203 funds tracked by Wall St. Rank held Zymeworks as of Q2 2026.

Based on SummitTX Capital's 13F filing for Q2 2026, filed 14 Aug 2026.